Market access risk by therapeutic area
MARA assesses reimbursement risk one drug and one indication at a time, and publishes each assessment with its "as of" date. This page is the map of that record: every therapeutic area MARA covers, in one place. The largest areas have a page of their own — a short account of what payers ask in that field, then the dated assessments. The remaining areas are listed here in full, grouped by area and newest first, until their own pages follow. When a drug has been re-assessed, the earlier version stays on the record beneath the current one, marked as replaced — never removed, never silently changed. Assessments are produced on MARA's own initiative for awareness; the current MARA Rating for any drug is available on request.
Areas with their own page
- Market access risk in oncology — 228 dated assessments
- Market access risk in neurology and psychiatry — 77 dated assessments
- Market access risk in immunology and rheumatology — 44 dated assessments
- Market access risk in cardiology — 27 dated assessments
- Market access risk in endocrinology and metabolism — 23 dated assessments
- Market access risk in hematology — 23 dated assessments
- Market access risk in gastroenterology and hepatology — 19 dated assessments
- Market access risk in nephrology — 17 dated assessments
- Market access risk in dermatology — 16 dated assessments
- Market access risk in ophthalmology — 16 dated assessments
- Market access risk in infectious diseases — 14 dated assessments
- Market access risk in respiratory medicine — 12 dated assessments
Gynecology — 4 dated assessments
- Fylrevy / estetrol for in Hormone Replacement Therapy in Postmenopausal Women as of May 2026
- Ryeqo for treating symptoms of endometriosis as of April 2025
- Linzagolix for treating moderate to severe symptoms of uterine fibroids as of August 2024
- Ryeqo for treating moderate to severe symptoms of uterine fibroids as of October 2022
Urology — 1 dated assessment
For how a MARA Rating is built, see the methodology and what a MARA Rating is. To request the current rating for any drug in any area, use the contact form.